SEMINAR ; Pr Alexis KALERGIS - Vaccine immunity counteracts respiratory virus-mediated suppression of immunological and neurological synapses
-
Le 24 January 2025Faculté d'Odontologie
Site CHU Hôtel DieuAmphi RICORDEAU
false false -
On January 24th 2025 at 11 am
Pr Alexis KALERGIS Professor and Director Millennium Institute on Immunology and Immunotherapy FOCIS Center of Excellence Pontificia Universidad Catolica de Chile Invited by Ignacio ANEGON Title : “Vaccine immunity counteracts respiratory virus-mediated suppression of immunological and neurological synapses “.
Dr. Alexis Kalergis is a Full Professor at the Schools of Biological Sciences and Medicine of the Pontificia Universidad Católica de Chile and a Doctor on Microbiology and Immunology at the Albert Einstein College of Medicine in New York. He did two postdoctoral studies at Albert Einstein and the Rockefeller University. He has been Visiting Professor at the Albert Einstein College of Medicine, the University of Nantes, France and the University of Iowa in the USA. He has given more than 400 national and international conferences and published 350 scientific articles. It has trained many young scientists, several of whom hold academic positions in Chile and abroad. He has received awards such as the Avonni National Innovation Award, the Andres Bello University Merit Award, the World Intellectual Property Organization Gold Medal, the Abdon Cifuentes Award that honors scientists with an impact on public policy, the Avonni Award for Innovative Career, the Image Spirit Award from Chile, and selected as one pf the 50 scientists that inspire worldwide by Cell Press, among others. He directs the Millennium Institute for Immunology and Immunotherapy, a center of excellence in international translational science. He has participated as an advisor in government and legislative commissions and as a member of the Scientific Advisory Council of the ICGEB (a United Nations Organization), of the Presidential Advisory Council for Science, Technology, Knowledge and Innovation of Chile, and the Advisory Council for the Directorate For Science, Technology And Innovation-Committee For Scientific And Technological Policy, OECD. He directed the scientific and clinical studies for one of the most advanced and safe COVID19 vaccines, which led to the preferential, priority and early supply of the necessary doses for the mass vaccination campaign against COVID-19 in Chile and several other countries.